ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0511

Association of Arterial Vascular Endothelial Growth Factor C Positivity with Arteriosclerotic Changes in Kidney Biopsy Specimens

Session Information

Category: Cardiovascular-Kidney-Metabolic Health

  • 602 Cardiovascular-Kidney-Metabolic Health: Clinical

Authors

  • Sanada, Satoru, Sendai Byoin, Sendai, Miyagi Prefecture, Japan
  • Sato, Mitsuhiro, Sendai Byoin, Sendai, Miyagi Prefecture, Japan
Background

Vascular endothelial growth factor-C (VEGF-C) is best known for its role in lymphangiogenesis, but it may also be involved in arteriosclerotic change. We examined the association between VEGF-C positivity and arteriosclerotic lesions in kidney biopsy specimens from patients with a range of clinical backgrounds.

Methods

Arterial VEGF-C immunostaining was evaluated in 183 consecutive kidney biopsy specimens. Arteriolar wall thickening and hyalinosis were graded histologically, and their associations with VEGF-C positivity were assessed. Baseline characteristics were compared between VEGF-C-positive and VEGF-C-negative cases using multivariable analysis. Circulating VEGF-C levels were measured by enzyme-linked immunosorbent assay.

Results

Among the 183 cases, 6 were excluded because the specimens lacked suitable arteries, 3 because clinical data were unavailable, and 17 because the patients were receiving steroid therapy. The remaining 157 biopsy specimens comprised 83 with positive arterial VEGF-C staining and 74 with negative staining. Histological arteriosclerotic scores, including arteriolar wall thickening and hyalinosis, were significantly higher in the VEGF-C-positive group. Patients with positive VEGF-C staining also tended to be older (60.9±15.2 vs 47.3±19.4, p<0.01), have higher serum creatinine levels (1.2±0.5 vs 0.9±0.4, p<0.01), and more frequently have hypertension (60% vs 30%, p<0.01), diabetes mellitus (24% vs 11%, p<0.01), and dyslipidemia (52% vs 34%, p=0.03). However, after adjustment for these factors in multivariable logistic regression analysis, only age remained significantly associated with VEGF-C positivity. Serum VEGF-C concentrations did not differ significantly between the VEGF-C-positive and VEGF-C-negative groups.

Conclusion

Arterial VEGF-C positivity may be associated with arteriosclerosis and may reflect the cumulative effects of aging and other common metabolic risk factors.